Rucha Patil on WFH Humanitarian Aid Program in India
Rucha Patil, Scientist, Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a proud post on LinkedIn:
”The World Federation of Hemophilia Humanitarian Aid Department, in collaboration with Hemophilia Federation (India) organized a valuable workshop in Delhi, India, on 12-13 July 2025 focused on the effective use of Extended Half-Life (EHL) treatment products. The workshop aimed to enhance the utilization of EHL donations and provide training to treaters from recipient Hemophilia Treatment Centres (HTCs) across India.
We are proud to share that our KEM-ICMR-NIIH HTC been able to initiate low-dose Immune Tolerance Induction (ITI) using EHL products, thanks to the generous support from WFH and achieve a 60% success rate—an outcome we had the opportunity to present at this important workshop.
We are deeply grateful to WFH for their continued support and impactful donations. Their efforts are making a real difference in the lives of our patients.”
Stay updated on the latest news in the field of hemophilia with Hemostasis Today.
-
Jul 31, 2025, 16:43Jason S Knight: Antiphospholipid Syndrome Review
-
Jul 31, 2025, 16:28William McKeown: Once or Twice Weekly Altuvoct? Insights
-
Jul 31, 2025, 16:07Thomas Reiser: Submit Your Research to JTH and RPTH
-
Jul 31, 2025, 15:56eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
-
Jul 31, 2025, 15:50Alfadil Haroon on Inherited Platelet Disorders: Know The Basics
-
Jul 31, 2025, 16:12Samin Mohsenian Shares the Final Open Access Version: Ob/Gyn Complications and Congenital Fibrinogen Disorders
-
Jul 31, 2025, 15:45Tzu-Fei Wang: To Anticoagulate or Not To Anticoagulate—That Is The Question
-
Jul 31, 2025, 15:12Wolfgang Miesbach: Protecting Liver Health in Bleeding Disorders
-
Jul 30, 2025, 16:24Cedric Hermans Invites You to Explore Hematologie Edition 2025 Nº 04
-
Jul 30, 2025, 15:53Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders